|
⚲
|
| Keyboard |
| Poirier Michael S
✚
|
|
|---|---|
| CIK # | 0001812504 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001812504] | |
| 4 | [0001812504] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ritter Pharmaceuticals Inc | |
| Poirier Michael S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2022-07-11 | Grant | 375,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2022-06-22 | Buy | 30,000 | $0.57 | 17,100 |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2021-04-20 | Buy | 11,005 | $1.80 | 19,809 |
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2020-06-06 | Grant | 1,000,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2020-05-22 | Other | 169,192 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 22,142 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 14,437 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 22,142 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 29,847 |